The 5th Circuit Court of Appeals ignored 23 years of scientific evidence when it restricted access to Mifepristone.
Although the 5th Circuit Court’s decision does not go as far as anti-abortion advocates might have hoped, it is still a grave threat to abortion access.
The National Women’s Health Network applauds the Supreme Court for its decision to block the lower court’s ruling against Mifepristone, one of two medication abortion drugs, until the end of the legal proceedings.
We are gravely concerned about this new nationwide barrier to abortion access.
On September 28 — the 20th anniversary of FDA’s approval of the abortion pill — we held a socially distanced protest in front of FDA headquarters and delivered the names of all 12,000+ of our petition signers.
Patients are turning to telehealth appointments and online pharmacies for routine medical care during the COVID-19 outbreak without having to leave their homes. But for most pregnant people seeking safe and effective abortion pills, the FDA has created a Byzantine set of rules that delay or block access to care.
The FDA says pregnant people can meet with their doctors remotely and have their abortion at home — but first, they must travel during a global pandemic just to pick up their pills.
FOR IMMEDIATE RELEASE Contact: Evita Almassi, [email protected]
FOR IMMEDIATE RELEASE Contact: Evita Almassi, [email protected] or (202) 682-6240